Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Retrospective medical chart review study to assess real world treatment patterns and outcomes in hospitalized patients with esophageal variceal hemorrhage (EVH) and liver cirrhosis treated with terlipressin in UK hospitals

X
Trial Profile

Retrospective medical chart review study to assess real world treatment patterns and outcomes in hospitalized patients with esophageal variceal hemorrhage (EVH) and liver cirrhosis treated with terlipressin in UK hospitals

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Terlipressin (Primary)
  • Indications Hepatorenal syndrome; Liver cirrhosis; Oesophageal varices; Variceal haemorrhage
  • Focus Therapeutic Use
  • Sponsors Mallinckrodt Group; Mallinckrodt plc
  • Most Recent Events

    • 28 Oct 2021 New trial record
    • 27 Oct 2021 Results assessing treatment patterns and outcomes in patients with EVH using real-world clinical data, presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021.
    • 25 Oct 2021 According to a Mallinckrodt Group media release, results from this trial were presented at the American College of Gastroenterology Annual Scientific Meeting 2021 being held virtually.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top